(Q44130854)

30 November 2017

title

Thiazolidinediones as a novel class of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors (English)

1 reference

30 November 2017

Hoon Cho

1

1 reference

30 November 2017

Hsin-Hsiung Tai

series ordinal

2

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Archives of Biochemistry and Biophysics

30 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 November 2017

volume

405

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

247-251

1 reference

15-Hydroxyprostaglandin dehydrogenase

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

The Biological Activities of Three Metabolites of Prostaglandin E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Regulation of prostaglandin metabolism: Activation of 15-hydroxyprostaglandin dehydrogenase by chlorpromazine and imipramine related drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

The synthesis of BRL 49653 - a novel and potent antihyperglycaemic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Prostacyclin as a potent effector of adipose-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in-vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900352-1

10.1016/S0003-9861(02)00352-1

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference